Deborah Quinn
2017
In 2017, Deborah Quinn earned a total compensation of $423.5K as Chief Medical Officer at Bellerophon Therapeutics, a 7% decrease compared to previous year.
Compensation breakdown
| Bonus | $120,000 |
|---|---|
| Salary | $303,461 |
| Total | $423,461 |
Quinn received $303.5K in salary, accounting for 72% of the total pay in 2017.
Quinn also received $120K in bonus.
Rankings
In 2017, Deborah Quinn's compensation ranked 12,430th out of 14,666 executives tracked by ExecPay. In other words, Quinn earned more than 15.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,430 out of 14,666 | 15th |
Division Manufacturing | 4,892 out of 5,772 | 15th |
Major group Chemicals And Allied Products | 1,792 out of 2,075 | 14th |
Industry group Drugs | 1,490 out of 1,731 | 14th |
Industry Pharmaceutical Preparations | 1,153 out of 1,333 | 14th |
Source: SEC filing on April 5, 2018.
Quinn's colleagues
We found two more compensation records of executives who worked with Deborah Quinn at Bellerophon Therapeutics in 2017.